Tomas Söderblom
Impact in
- Endocrinology top 2%
- Escherichia coli research studies
- Vibrio bacteria research studies
- Microbiology top 2%
- Bacterial Infections and Vaccines
Papers in
-
- Escherichia coli research studies 3
-
- Clostridium difficile and Clostridium perfringens research 3
- Antimicrobial Resistance in Staphylococcus 2
- Co-authors
- Agneta Richter‐Dahlfors (6 shared papers)Bernt Eric Uhlin (2 shared papers)Sun Nyunt Wai (2 shared papers)Yoshimitsu Mizunoe (1 shared paper)Jana Jaß (1 shared paper)Jan Oscarsson (1 shared paper)Marie Westermark (1 shared paper)Barbro Lindmark (1 shared paper)
In The Last Decade
Tomas Söderblom
11 papers receiving 874 citations
Peers
Comparison fields: 5 of 77
- Endocrinology 270
- Microbiology 273
- Molecular Medicine 125
- Applied Microbiology and Biotechnology 14
- Infectious Diseases 125
Countries citing papers authored by Tomas Söderblom
This map shows the geographic impact of Tomas Söderblom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Söderblom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Söderblom more than expected).
Fields of papers citing papers by Tomas Söderblom
This network shows the impact of papers produced by Tomas Söderblom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Söderblom. The network helps show where Tomas Söderblom may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomas Söderblom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 445 | |
| 2 | 2000 | 220 | |
| 3 | 2013 | 67 | |
| 4 | 2005 | 58 | |
| 5 | 2010 | 36 | |
| 6 | 2006 | 20 | |
| 7 | 2003 | 14 | |
| 8 | 2001 | 13 | |
| 9 | 2014 | 12 | |
| 10 | 2003 | 9 | |
| 11 | 2007 | 2 |
About Tomas Söderblom
Tomas Söderblom is a scholar working on Endocrinology, Infectious Diseases, Molecular Biology, Epidemiology and Clinical Biochemistry, having authored 11 papers that have together received 896 indexed citations. Recurring topics across this work include Escherichia coli research studies (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Pneumonia and Respiratory Infections (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Antibiotic Resistance in Bacteria (2 papers), Antibiotic Use and Resistance (1 paper) and Streptococcal Infections and Treatments (1 paper). The work is most often cited by research in Endocrinology (270 citations), Microbiology (273 citations), Molecular Medicine (125 citations), Applied Microbiology and Biotechnology (14 citations) and Infectious Diseases (125 citations). Tomas Söderblom has collaborated with scholars based in Sweden, Czechia and Japan. Frequent co-authors include Agneta Richter‐Dahlfors, Bernt Eric Uhlin, Sun Nyunt Wai, Yoshimitsu Mizunoe, Jana Jaß, Jan Oscarsson, Marie Westermark, Barbro Lindmark, Akemi Takade and Anita Aperia. Their work appears in journals such as International Journal of Medical Microbiology, Clinical Microbiology and Infection, Cellular Microbiology, Eurosurveillance and Pediatric Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.